Public Service Announcements
Through television and radio, public service announcements play a vital role in increasing awareness and encouraging early detection of colon cancer.
With early detection via screening, colorectal cancer is a highly treatable and preventable cancer. “But," due to hectic lifestyles or just “stuff," many Americans push off their screenings. A third of screening-eligible adults are missing their chance to prevent CRC. Don’t let “but, stuff” get in the way of your screening. Because, when it comes to screening, tomorrow can’t wait.
That’s why the Colorectal Cancer Alliance has launched a new television and radio public service announcement (PSA) to educate the public about the importance of colorectal cancer screenings. On-time screening – beginning at age 45 – is essential to catch it early and is the No. 1 way to prevent it. Localized colorectal cancer (the earliest stage) has a 91% survival rate with treatment.
Increase awareness about the importance of colorectal cancer screenings – to improve cancer outcomes and save lives! View, download, and use the following PSAs. Please contact us at email@example.com or at (609) 748-7411 if you require this PSA in another format or delivery method.
The TV PSAs include 60, 30, and two 15-second versions.
The radio PSAs include 60, 30, and 15-second versions.
Don’t let “but, stuff” stop you from getting your colorectal cancer screening. Contact our team if you need additional assistance with using the Alliance's PSAs.
Whether personally impacted by colorectal cancer (CRC), supporting a loved one, or dedicated to educating and empowering others, these downloadable and printable resources can help.
Initiative aims to reduce stigma and educate about screening choices, as the Colorectal Cancer Alliance launches a health equity fund to decrease disparities.
On the horizon are blood tests that have shown the ability to detect a variety of cancers including colorectal and rare cancers. Though these tests are still in development and are not yet approved by the FDA, clinical trials have shown impressive results.